A phase I/II trial of cabozantinib (C) with or without panitumumab (P) in patients (pts) with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Clinical outcomes in pts with MET amplification (amp) detected in blood.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Jia, J; Niedzwiecki, D; Uronis, HE; Morse, M; Zafar, Y; Hsu, SD; Bolch, E; Nagy, RJ; Lanman, RB; Talasaz, A; Haley, S; Nixon, AB; Strickler, JH

Published Date

  • May 20, 2018

Published In

Volume / Issue

  • 36 / 15_suppl

Start / End Page

  • 3555 - 3555

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2018.36.15_suppl.3555